Verition Fund Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-555,392
| Closed | -$159K | – | 2339 |
|
|
2023
Q3 | $159K | Sell |
555,392
-34,108
| -6% | -$9.75K | ﹤0.01% | 1685 |
|
|
2023
Q2 | $282K | Sell |
589,500
-13,907
| -2% | -$6.66K | ﹤0.01% | 1378 |
|
|
2023
Q1 | $392K | Buy |
603,407
+64,356
| +12% | +$41.8K | 0.01% | 1266 |
|
|
2022
Q4 | $253K | Hold |
539,051
| – | – | ﹤0.01% | 1264 |
|
|
2022
Q3 | $447K | Hold |
539,051
| – | – | 0.01% | 1550 |
|
|
2022
Q2 | $631K | Hold |
539,051
| – | – | 0.01% | 1256 |
|
|
2022
Q1 | $685K | Hold |
539,051
| – | – | 0.01% | 1121 |
|
|
2021
Q4 | $879K | Hold |
539,051
| – | – | 0.01% | 966 |
|
|
2021
Q3 | $1.49M | Hold |
539,051
| – | – | 0.01% | 569 |
|
|
2021
Q2 | $1.62M | Hold |
539,051
| – | – | 0.01% | 516 |
|
|
2021
Q1 | $2.2M | Sell |
539,051
-600
| -0.1% | -$2.45K | 0.02% | 314 |
|
|
2020
Q4 | $2.53M | Buy |
+539,651
| New | +$2.53M | 0.02% | 257 |
|